Suzuki K - Search Results

1

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.

Mateos MV, Blacklock H, Schjesvold F, Oriol A, Simpson D, George A, Goldschmidt H, Larocca A, Chanan-Khan A, Sherbenou D, Avivi I, Benyamini N, Iida S, Matsumoto M, Suzuki K, Ribrag V, Usmani SZ, Jagannath S, Ocio EM, Rodriguez-Otero P, San Miguel J, Kher U, Farooqui M, Liao J, Marinello P, Lonial S; KEYNOTE-183 Investigators. Mateos MV, et al. Among authors: suzuki k. Lancet Haematol. 2019 Sep;6(9):e459-e469. doi: 10.1016/S2352-3026(19)30110-3. Epub 2019 Jul 18. Lancet Haematol. 2019. PMID: 31327687 Clinical Trial.

2

Current therapeutic strategy for multiple myeloma.

Suzuki K. Suzuki K. Jpn J Clin Oncol. 2013 Feb;43(2):116-24. doi: 10.1093/jjco/hys215. Epub 2013 Jan 4. Jpn J Clin Oncol. 2013. PMID: 23293370 Review.

3

Phase I/II study of bortezomib-melphalan-prednisolone for previously untreated Japanese patients with multiple myeloma.

Ogawa Y, Suzuki K, Sakai A, Iida S, Ogura M, Tobinai K, Matsumoto M, Matsue K, Terui Y, Ohashi K, Ishii M, Mukai HY, Ando K, Hotta T. Ogawa Y, et al. Among authors: suzuki k. Cancer Sci. 2013 Jul;104(7):912-9. doi: 10.1111/cas.12172. Epub 2013 May 27. Cancer Sci. 2013. PMID: 23574271 Free PMC article. Clinical Trial.

4

[Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].

Hamano A, Shingaki S, Abe Y, Miyazaki K, Sekine R, Nakagawa Y, Tsukada N, Hattori Y, Suzuki K. Hamano A, et al. Among authors: suzuki k. Rinsho Ketsueki. 2014 Apr;55(4):428-35. Rinsho Ketsueki. 2014. PMID: 24850453 Japanese.

5

Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma.

Suzuki K, Ogura M, Abe Y, Suzuki T, Tobinai K, Ando K, Taniwaki M, Maruyama D, Kojima M, Kuroda J, Achira M, Iizuka K. Suzuki K, et al. Among authors: suzuki t. Int J Hematol. 2015 Mar;101(3):286-94. doi: 10.1007/s12185-015-1743-y. Epub 2015 Feb 6. Int J Hematol. 2015. PMID: 25655379 Clinical Trial.

6

Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma.

Watanabe T, Mitsuhashi M, Sagawa M, Ri M, Suzuki K, Abe M, Ohmachi K, Nakagawa Y, Nakamura S, Chosa M, Iida S, Kizaki M. Watanabe T, et al. Among authors: suzuki k. PLoS One. 2015 Jun 26;10(6):e0128662. doi: 10.1371/journal.pone.0128662. eCollection 2015. PLoS One. 2015. PMID: 26115406 Free PMC article.

7

[Graft-versus-host disease associated with lenalidomide maintenance after allogeneic transplantation for relapsed/refractory multiple myeloma].

Tsukada N, Shingaki S, Ikeda M, Miyazaki K, Meshitsuka S, Yoshiki Y, Abe Y, Suzuki K. Tsukada N, et al. Among authors: suzuki k. Rinsho Ketsueki. 2015 Jul;56(7):895-900. doi: 10.11406/rinketsu.56.895. Rinsho Ketsueki. 2015. PMID: 26256927 Japanese.

8

[Induction treatment with bortezomib-cyclophosphamide-dexamethasone (CyBorD) for newly diagnosed transplant-eligible patients with multiple myeloma].

Tsukada N, Ikeda M, Shingaki S, Miyazaki K, Meshitsuka S, Yoshiki Y, Abe Y, Suzuki K. Tsukada N, et al. Among authors: suzuki k. Rinsho Ketsueki. 2015 Aug;56(8):1069-75. doi: 10.11406/rinketsu.56.1069. Rinsho Ketsueki. 2015. PMID: 26345569 Japanese.

9

Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma.

Mu S, Kuroda Y, Shibayama H, Hino M, Tajima T, Corrado C, Lin R, Waldron E, Binlich F, Suzuki K. Mu S, et al. Among authors: suzuki k. Eur J Clin Pharmacol. 2016 Feb;72(2):153-61. doi: 10.1007/s00228-015-1967-z. Epub 2015 Oct 22. Eur J Clin Pharmacol. 2016. PMID: 26494130 Free PMC article. Clinical Trial.

10

[The clinical significance of decrease in CD138 positive cell ratio in multiple myeloma].

Inoue J, Ikeda M, Shingaki S, Miyazaki K, Meshitsuka S, Abe Y, Sekine R, Tsukada N, Hattori Y, Suzuki K. Inoue J, et al. Among authors: suzuki k. Rinsho Ketsueki. 2015 Nov;56(11):2311-7. doi: 10.11406/rinketsu.56.2311. Rinsho Ketsueki. 2015. PMID: 26666717 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,692 results

Search Page

Filters